JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hitzel, A.
Right arrow Articles by Dacher, J.-N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hitzel, A.
Right arrow Articles by Dacher, J.-N.
Journal of Nuclear Medicine Vol. 43 No. 1 27-32
© 2002 by Society of Nuclear Medicine


Clinical Investigations

Color and Power Doppler Sonography Versus DMSA Scintigraphy in Acute Pyelonephritis and in Prediction of Renal Scarring

Anne Hitzel, MD1, Agnès Liard, MD2, Pierre Véra, MD, PhD1, Alain Manrique, MD1, Jean-François Ménard, PhD3 and Jean-Nicolas Dacher, MD, PhD4

1 Department of Nuclear Medicine, Centre Henri Becquerel, Rouen, France
2 Department of Pediatric Surgery, Centre Hospitalier Universitaire Charles Nicolle, Rouen, France
3 Department of Biostatistics, Centre Hospitalier Universitaire Charles Nicolle, Rouen, France
4 Department of Radiology, Centre Hospitalier Universitaire Charles Nicolle, Rouen, France

Capabilities of color and power Doppler sonography (DS) were prospectively evaluated for diagnosis of acute pyelonephritis and for prediction of scarring by comparison with 99mTc-dimercaptosuccinic acid scintigraphy (DMSA). Methods: Fifty-seven children (mean age, 5 ± 3 y) with acute pyelonephritis were investigated by biologic testing, DS (DS 1), and DMSA (DMSA 1). Patients who were <6 mo old or had high-grade reflux or obstruction were excluded. Forty-five children had a clinical follow-up examination, biologic testing, DS (DS 2), and DMSA (DMSA 2) at a mean of 7 ± 2 mo after acute infection. Sonography (gray-scale and DS) was performed by 1 experienced radiologist who was unaware of patient data. DMSA studies were interpreted by 2 physicians who were unaware of patient data. Results: Temperature, neutrophil count, and C-reactive protein value were significantly higher in patients with abnormal DMSA 1 findings than in those with abnormal DS 1 findings (P < 0.05). When compared with DMSA 1, DS 1 had a sensitivity and specificity of 80% and 81%, respectively. At follow-up, all clinical and biologic data had normalized. Scarring after infection occurred in 51% of children. When compared with DMSA 2, DS 1 had positive and negative predictive values of 57% and 75%, respectively, and DMSA 1 had respective values of 62% and 100%. Reflux was not considered a good predictor of scarring. Conclusion: DS and DMSA results were concordant in 81% of kidneys with acute pyelonephritis. The predictive value of DS for renal scarring was not considered sufficiently high for DS to be used in routine practice.

Key Words: kidney • infection • sonography • radionuclide studies




This article has been cited by other articles:


Home page
Arch. Dis. Child.Home page
I Moorthy, M Easty, K McHugh, D Ridout, L Biassoni, and I Gordon
The presence of vesicoureteric reflux does not identify a population at risk for renal scarring following a first urinary tract infection
Arch. Dis. Child., July 1, 2005; 90(7): 733 - 736.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. Hitzel, A. Liard, J.-N. Dacher, I. Gardin, J.-F. Menard, A. Manrique, and P. Vera
Quantitative Analysis of 99mTc-DMSA During Acute Pyelonephritis for Prediction of Long-Term Renal Scarring
J. Nucl. Med., February 1, 2004; 45(2): 285 - 289.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.